No Data
No Data
Orna Therapeutics Announces Presentation at the American Society of Gene and Cell Therapy Annual Meeting Supporting Its in Vivo CAR Therapy Approach in Autoimmune Diseases
ORNA To Go Ex-Dividend On May 5th, 2025 With 0.02 MYR Dividend Per Share
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Express News | ORNA Reports FY24Q4 Attributable Profit of RM2.1 Million, Down 61.9% YoY
ORNA: Quarterly rpt on consolidated results for the financial period ended 31/12/2024
Services Sector Hits New High With RM2.4 Trillion Boom